Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AMLX
ARQT
Add up to 3 more stocks
AMLX
Amylyx Pharmaceuticals, Inc.
-1.44%
$27.38-0.40Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$3.04B
52W Range
$10.83 - $41.14
ARQT
Arcutis Biotherapeutics, Inc.
-2.90%
$24.42-0.73Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$3.05B
52W Range
$19.30 - $31.77
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 117.12 |
| Forward P/E | N/A | 49.12 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 12.73 | 13.85 |
| P/S Ratio | N/A | 6.58 |
| P/FCF Ratio | N/A | 78.02 |
| EV/EBITDA | N/A | 84.26 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 91.1% |
| Operating Margin | 0.0% | -3.3% |
| Net Margin | 0.0% | 6.2% |
| ROE | -63.6% | 12.9% |
| ROA | -57.5% | 5.8% |
| ROIC | -66.6% | 9.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.12 | 2.92 |
| Quick Ratio | 12.12 | 2.67 |
| Debt/Equity | 0.02 | 0.52 |
| Interest Coverage | N/A | -1.01 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.